ANAND SUBRAMANIAN IYER

      DIN: 01322598

      For latest information about the director, visit MCA.

      ANAND SUBRAMANIAN IYER is a director registered with Ministry of Corporate Affairs. Their Director Identification Number (DIN) is 01322598. ANAND SUBRAMANIAN IYER is/has been associated with 19 companies.

      This is just one Director. Want to discover lot more?

      Unlock deeper insights with Prime Research AI

      Companies Associated With

      Company Designation Date of Appointment
      HUMAATRIX BUSINESS SOLUTIONS LLP Designated Partner 19-Dec-2025
      AKP HEALTHCARE PRIVATE LIMITED Director 25-Nov-2021
      MAHAVEER MEDI-SALES PRIVATE LIMITED Director 25-Nov-2021
      ARYAN WELLNESS PRIVATE LIMITED Director 24-Jan-2022
      ENRON SECURITIES PRIVATE LIMITED Director 02-Sep-2009
      CALLSTREET SOLUTIONS INDIA PRIVATE LIMITED Director 03-Jan-2008
      J. A. CREDIT CONSULTANTS PRIVATE LIMITED Director 28-Jul-2003

      Past Companies Associated With

      Company Designation Date of Appointment Date of Cessation
      AUSHAD PHARMA DISTRIBUTORS PRIVATE LIMITED Additional Director 24-Jan-2022 29-Mar-2022
      AKP HEALTHCARE PRIVATE LIMITED Additional Director 25-Nov-2021 24-Sep-2022
      MAHAVEER MEDI-SALES PRIVATE LIMITED Additional Director 25-Nov-2021 24-Sep-2022
      ARYAN WELLNESS PRIVATE LIMITED Additional Director 24-Jan-2022 24-Sep-2022
      MUTHU PHARMA PRIVATE LIMITED Additional Director 25-Nov-2021 25-Jan-2022
      DHANAYU FINANCE PRIVATE LIMITED Director 31-Aug-2024 08-Dec-2025
      ENRON SECURITIES PRIVATE LIMITED Additional Director 27-Jul-2009 02-Sep-2009
      D. C. AGENCIES PRIVATE LIMITED Additional Director 25-Nov-2021 25-Jan-2022
      EASTERN AGENCIES HEALTHCARE PRIVATE LIMITED Additional Director 25-Nov-2021 25-Jan-2022
      AYRO RETAIL SOLUTIONS PRIVATE LIMITED Additional Director 25-Nov-2021 14-Jan-2022
      REENAV PHARMA PRIVATE LIMITED Additional Director 24-Jan-2022 24-Sep-2022
      REENAV PHARMA PRIVATE LIMITED Director 24-Sep-2022 31-Dec-2024

      “Assess financial performance of all companies under a director.”

      Explore Prime Research Explore for Sales